SuspendedNCT05394545
Phase II Trial of Nu-V3 Non-Invasive Nerve Stimulation Device for Chronic Pain, Anxiety, Depression, Sleeplessness
Device studyAges 18+United States
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Schaumburg and 1 more locationSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: March 20, 2024
- Recruitment status
- Suspended
- Enrollment listed in the registry
- 80
- Sponsor
- Nu-Life Solutions
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT05394545
- Official title
Show the full official title
A Randomized, Phase II, Open-Label Study Evaluating the Nu-V3 Cranial Nerve Stimulation Treatment Device in Patients With Chronic Pain, Anxiety, Depression, and/or Sleeplessness
Recruitment & locations
SuspendedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Schaumburg · Greenwood
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nu-Life Solutions.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as suspended.
